News | 25/09/2025
Congress of the European College of Neuropsychopharmacology (ECNP)

Strong PSY-PGx presence at the 2025 ECNP Congress in Amsterdam!

Five posters to be presented
The PSY-PGx project will be boldly represented at this year's ECNP congress in Amsterdam! If you are attending the congress, do not miss these posters:

Kristian Kleine Schaars (Amsterdam)

EP12-1149: A UK biobank analysis of pharmacogenetics CYP2C19 and CYP2D6 and clinical outcome in mood disorder adults, ePoster session 12 - Transdiagnostic - Date: 14 October 202


Natalia Fares (Barcelona)

PS01-0209 – Pharmacogenetic-guided antidepressant treatment on functional outcome in anxiety and affective disorders: A systematic review and meta-analysis, Date: 11 October 2025 / Time: 12:00 – 13:25


Emma de Brabander (Maastricht)

PS01-0256: Knowledge and Attitudes Regarding Pharmacogenetics of Pharmacists in the Netherlands: A National Online Survey Study, Saturday 11-10-25, 12:00-13


Emma Redaelli (Amsterdam and Milan)

EP12-1145 Impact of pharmacogenetics in psychiatric clinical practice: a case report showing a personalised treatment option, 14 October, 8:00–8:30


Sanah Bedi (Amsterdam)

Title – “Two cases demonstrating the clinical impact of pharmacogenetic-guided treatment.”, ePoster session 8 - Pharmacological interventions and psychedelics, Date: 13 October 2025, Time: 08:00 - 08:30, Location: online